Balance Sheet Components |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2026 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Balance Sheet Components | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Balance Sheet Components | 7.Balance Sheet Components Restricted Cash Restricted cash consists of cash pledged as collateral for stand-by letters of credit of $1.4 million and $1.3 million as of June 30, 2026 and December 31, 2025, respectively. Substantially all of the restricted cash relates to lease commitments and will remain restricted until the termination or modification of the underlying lease agreements. Restricted cash was classified as non-current in the condensed consolidated balance sheets as of June 30, 2026 and December 31, 2025. Other Prepaid Expenses and Current Assets Other prepaid expenses and current assets consisted of the following as of June 30, 2026 and December 31, 2025 (in thousands):
The prepaid credit voucher for clinical manufacturing was received by ACELYRIN in the third quarter of 2024 as part of an agreement to cancel certain services with a vendor under a manufacturing agreement related to the suspension of development of certain ACELYRIN programs. The prepaid credit voucher for clinical manufacturing may be used to settle invoices for services and raw materials from this vendor related to the lonigutamab product candidate. As of June 30, 2026, the prepaid credit voucher for clinical manufacturing included $13 thousand classified in other prepaid expenses and current assets and $0.9 million included in other assets, non-current. Property and Equipment, Net Property and equipment, net consisted of the following as of June 30, 2026 and December 31, 2025 (in thousands):
Depreciation and amortization expense was $0.8 million and $0.9 million for the three months ended June 30, 2026 and 2025, respectively and $1.7 million for each of the six months ended June 30, 2026 and 2025. Other Accrued Expenses and Current Liabilities Other accrued expenses and current liabilities consisted of the following as of June 30, 2026 and December 31, 2025 (in thousands):
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||